Surgical Treatment of Patients with Adenocarcinoma of the Distal Esophageal Portion and Gastroesophageal Junction Performed After Neoadjuvant Chemotherapy and Combined Chemoradiation

Esophageal carcinoma is an extremely aggressive cancer with an early distant spread, high rate of local recurrence, and low overall survival. Herewith we present 3 patients with advanced moderately and low differentiated adenocarcinomas, who underwent neoadjuvant chemotherapy (nCT) (two patients) an...

Full description

Bibliographic Details
Published in:	Acta Medica Bulgarica
Main Authors:	Yankov G., Alexieva M., Kovacheva-Slavova M., Vladimirov B., Mekov E.
Format:	Article
Language:	English
Published:	Sciendo 2022-04-01
Subjects:	adenocarcinoma esophageal carcinoma neoadjuvant therapy gastrectomy gastroesophagoplasty esophagojejunoplasty
Online Access:	https://doi.org/10.2478/amb-2022-0007

Similar Items

Short-term Outcomes in Patients with Carcinoma of the Esophagus and Gastroesophageal Junction Receiving Neoadjuvant Chemotherapy or Chemoradiation before Surgery. A Prospective Study
by: Syed Nusrath, et al.
Published: (2019-01-01)

DNA methylation biomarkers accurately detect esophageal cancer prior and post neoadjuvant chemoradiation
by: Catarina Macedo‐Silva, et al.
Published: (2023-04-01)

Active surveillance in patients with a complete clinical response after neoadjuvant chemoradiotherapy for esophageal- and gastroesophageal junction cancer
by: Huizer Tamara J., et al.
Published: (2024-11-01)

Pathologic complete response in patients with esophageal cancer receiving neoadjuvant chemotherapy or chemoradiation: A systematic review and meta‐analysis
by: Charles E. Gaber, et al.
Published: (2024-02-01)

The Effect of Neoadjuvant Therapy on Early Complications of Esophageal Cancer Surgery
by: Mohammadtaghi Rajabi Mashhadi, et al.
Published: (2015-07-01)

Indications for neoadjuvant radiation in esophageal adenocarcinoma: Times are changingCentral Message
by: Stephanie G. Worrell, MD, FACS
Published: (2024-06-01)

To compare and determine the diagnostic accuracy of [18F]-fluorodeoxyglucose positron emission tomography scan in predicting pathological response in operated carcinoma esophagus patients after initial neoadjuvant chemoradiation and neoadjuvant chemotherapy
by: Neelam Sharma, et al.
Published: (2018-04-01)

Neoadjuvant immunochemotherapy for resectable esophageal cancer: A study on efficacy and safety
by: Xiaomin Wang, et al.
Published: (2025-04-01)

A clinical trial of neoadjuvant concurrent chemoradiotherapy followed by resection for esophageal carcinoma
by: Kazem Anvari, et al.
Published: (2015-01-01)

Efficacy and safety of neoadjuvant immunotherapy combined with chemotherapy for stage II–IVa esophageal cancer: a network meta-analysis
by: Mingxing Wang, et al.
Published: (2025-01-01)

Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index
by: Jiyoun Park, et al.
Published: (2025-03-01)

Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma
by: Xiao Liu, et al.
Published: (2024-04-01)

Editorial: The role of adjuvant and neoadjuvant therapy in resectable esophageal cancer
by: Xiaokun Li, et al.
Published: (2025-09-01)

A randomized phase 3 trial of total neoadjuvant therapy (induction chemotherapy, neoadjuvant chemoradiation, neoadjuvant chemotherapy, and surgery) vs. standard long-term chemoradiation therapy (neoadjuvant chemoradiation, surgery, and adjuvant chemotherapy) in locally advanced rectal cancer
by: Freshte Foroughi, et al.
Published: (2024-12-01)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
by: Weiming Han, et al.
Published: (2022-11-01)

A Prospective Study of Early Radiation Associated Cardiac Toxicity Following Neoadjuvant Chemoradiation for Distal Esophageal Cancer
by: Aidan M. Burke, et al.
Published: (2020-08-01)

Neoadjuvant chemoimmunotherapy versus neoadjuvant chemoradiotherapy in patients with borderline resectable esophageal squamous cell carcinoma
by: Jun-Peng Lin, et al.
Published: (2025-08-01)

Short- and long-term outcomes of laparoscopic versus open gastrectomy after neoadjuvant chemotherapy: A case-control study using a propensity score matching method
by: Qinchuan Yang, et al.
Published: (2023-12-01)

Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for clinical node‐negative esophageal carcinoma
by: Hui‐Jiang Gao, et al.
Published: (2020-09-01)

Evaluation of neoadjuvant immunotherapy and traditional neoadjuvant therapy for resectable esophageal cancer: a systematic review and single-arm and network meta-analysis
by: Hesong Wang, et al.
Published: (2023-05-01)

Definitive Chemoradiation for Gastroesophageal junction (GEJ) Adenocarcinomas: A Single-Institution Experience
by: Farshid Farhan, et al.
Published: (2024-04-01)

Neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy for resectable esophageal squamous cell carcinoma: a clinical retrospective study
by: Jiazhen Chen, et al.
Published: (2025-08-01)

Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma
by: Zhen Wang, et al.
Published: (2022-06-01)

Recent Advances and Hot Spots of Neoadjuvant Immunotherapy Combined with Chemotherapy for Esophageal Carcinoma
by: Huilai LYU, et al.
Published: (2024-12-01)

Prognostic analysis of esophageal cancer patients after neoadjuvant therapy
by: Jing Dong, et al.
Published: (2025-02-01)

The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancerCentral MessagePerspective
by: Lye-Yeng Wong, MD, et al.
Published: (2023-06-01)

Evaluation of survival and recurrence patterns in esophageal cancer patients with pathological response to neoadjuvant chemoradiotherapy
by: Ali Kermani, et al.
Published: (2020-01-01)

Overall Survival Results with Surgical Treatment After Neoadjuvant Chemotherapy in Local Invasive Gastric Cancers
by: Gökhan Ertuğrul
Published: (2019-04-01)

The application of radiomics in esophageal cancer: Predicting the response after neoadjuvant therapy
by: Hai Guo, et al.
Published: (2023-04-01)

Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study)
by: Hai-Yu Zhou, et al.
Published: (2020-07-01)

Neoadjuvant Concurrent Chemoradiation in Locally Advanced Adenocarcinoma of Gastroesophageal Junction & Proximal Stomach (A Single Arm Study): Our Experience From Single Institute From Kashmir Valley
by: Murtaza Shafi, et al.
Published: (2023-01-01)

Exploration of individualized neoadjuvant therapy model for operable esophageal cancer: A Surveillance, Epidemiology, and End Results database analysis
by: Xingyu Zhou, et al.
Published: (2024-12-01)

Nodal Downstaging of Esophageal Cancer After Neoadjuvant Therapy: A Cohort Study and Meta‐Analysis
by: Feng Su, et al.
Published: (2025-02-01)

Case report: A case study of neoadjuvant immunochemotherapy for locally advanced esophageal squamous carcinoma
by: Xiong Liu, et al.
Published: (2024-07-01)

Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy
by: Jae Kwang Yun, et al.
Published: (2022-10-01)

Neoadjuvant Chemoradiotherapy Improving Survival Outcomes for Esophageal Carcinoma: An Updated Meta-analysis
by: Dong-Bin Wang, et al.
Published: (2016-01-01)

Neoadjuvant treatment of esophageal cancer: chemotherapy, chemoradiation, immunotherapy, and future trends of therapy
by: Malekzada Freschta, et al.
Published: (2024-11-01)

Pathologic responses and surgical outcomes after neoadjuvant immunochemotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
by: Lei Xu, et al.
Published: (2022-11-01)

Short-term outcomes of robotic vs. laparoscopic surgery for gastric cancer after neoadjuvant therapy: a systematic review and meta-analysis
by: Tuerjun Tuohuti, et al.
Published: (2025-06-01)

Neoadjuvant chemoimmunotherapy was associated with better short‐term survival of patients with locally advanced esophageal squamous cell carcinoma compared to neoadjuvant chemoradiotherapy
by: Xiaofeng Duan, et al.
Published: (2024-08-01)